These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 21291513)
1. Emerging targets for the treatment of obesity. Suwa A; Shimokawa T FEBS J; 2011 Feb; 278(4):551. PubMed ID: 21291513 [No Abstract] [Full Text] [Related]
2. Lipid metabolic enzymes: emerging drug targets for the treatment of obesity. Shi Y; Burn P Nat Rev Drug Discov; 2004 Aug; 3(8):695-710. PubMed ID: 15286736 [No Abstract] [Full Text] [Related]
3. Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines. Correia ML; Haynes WG Expert Opin Emerg Drugs; 2005 Aug; 10(3):643-60. PubMed ID: 16083333 [TBL] [Abstract][Full Text] [Related]
4. Challenges in the discovery and development of new agents for the treatment of obesity. Staten MA Clin Pharmacol Ther; 2007 May; 81(5):753-5. PubMed ID: 17377527 [TBL] [Abstract][Full Text] [Related]
5. The success of bariatric surgery as treatment of type 2 diabetes should be a call to revitalize anti-obesity drug discovery and development. Opgenorth TJ Curr Opin Investig Drugs; 2008 Apr; 9(4):355-6. PubMed ID: 18393101 [No Abstract] [Full Text] [Related]
6. Emerging pharmacological approaches to the treatment of obesity. Wasan KM; Looije NA J Pharm Pharm Sci; 2005 Aug; 8(2):259-71. PubMed ID: 16124937 [TBL] [Abstract][Full Text] [Related]
7. Development of novel medications for use in the treatment of obesity in children will be directed by delineating controls of energy homeostasis. Sherman PM; Zlotkin SH Arch Pediatr Adolesc Med; 2003 Aug; 157(8):721. PubMed ID: 12912773 [No Abstract] [Full Text] [Related]
9. [Molecular targets for new drug discovery to treat type 2 diabetes and obesity]. Bastarrachea RA; Montero JC; Saavedra-Gajardo I; Cerda-Flores R; Machado-DomÃnguez A; Comuzzie AG Rev Med Chil; 2008 Jan; 136(1):107-17. PubMed ID: 18483661 [TBL] [Abstract][Full Text] [Related]
10. Modulation of neuropeptide Y receptors for the treatment of obesity. Sato N; Ogino Y; Mashiko S; Ando M Expert Opin Ther Pat; 2009 Oct; 19(10):1401-15. PubMed ID: 19743896 [TBL] [Abstract][Full Text] [Related]
11. The search for quick and easy measures to combat obesity. Health Care Food Nutr Focus; 2004 Aug; 21(8):8-9. PubMed ID: 15473191 [No Abstract] [Full Text] [Related]
12. [Xenical--a modern perspective drug for the treatment of obesity (review)]. Mkrtumian AM; Biriukova EV Ter Arkh; 2007; 79(10):35-9. PubMed ID: 18154143 [No Abstract] [Full Text] [Related]
13. Melanocortin-4 receptor (MC4R) agonists for the treatment of obesity. Nargund RP; Strack AM; Fong TM J Med Chem; 2006 Jul; 49(14):4035-43. PubMed ID: 16821763 [No Abstract] [Full Text] [Related]
14. Pharmaceutical approaches to the treatment of obesity. Jandacek RJ; Woods SC Drug Discov Today; 2004 Oct; 9(20):874-80. PubMed ID: 15475320 [TBL] [Abstract][Full Text] [Related]
15. Obesity drugs and their targets: correlation of mouse knockout phenotypes with drug effects in vivo. Powell DR Obes Rev; 2006 Feb; 7(1):89-108. PubMed ID: 16436105 [TBL] [Abstract][Full Text] [Related]
16. [Combination of drug therapy and changing life-style on weight loss success]. Ziegler R Med Monatsschr Pharm; 2006 Jun; 29(6):231-2. PubMed ID: 16792205 [No Abstract] [Full Text] [Related]
17. Prospects for an anti-ghrelin vaccine to treat obesity. Carlson MJ; Cummings DE Mol Interv; 2006 Oct; 6(5):249-52. PubMed ID: 17035664 [TBL] [Abstract][Full Text] [Related]
18. [The outlook in the treatment of obesity in adults]. Caviezel F Recenti Prog Med; 1999 Apr; 90(4):193-5. PubMed ID: 10354730 [No Abstract] [Full Text] [Related]
19. Obesity Drug Development Summit. 21-22 July, 2005, Arlington, VA, USA. Maggio CA IDrugs; 2005 Sep; 8(9):701-3. PubMed ID: 16118685 [TBL] [Abstract][Full Text] [Related]
20. An herbal weight-loss drug fails in rigorous testing. Harv Heart Lett; 1999 Mar; 9(7):6. PubMed ID: 10066295 [No Abstract] [Full Text] [Related] [Next] [New Search]